Literature DB >> 17141963

Apolipoprotein E epsilon4 offers protection against age-related macular degeneration.

Duncan A Friedman1, Walter J Lukiw, James M Hill.   

Abstract

BACKGROUND: In many previous studies, age-related macular degeneration (ARMD) has been linked to a variety of different risk factors. The publications have debated whether apolipoprotein E (apoE) epsilon4 serves as a potential protective factor in the development of the disease. Other studies have classified the behavior of this protein in different pathologies, including Alzheimer's disease (AD) and cardiovascular disease. The general behavior of the epsilon4 isoform of ApoE is different than the predominant epsilon3 isoform. HYPOTHESIS: We propose that the general characteristics and molecular behavior of apoE epsilon4 cause it to be a protective factor against the development of ARMD by preventing cumulative effects of oxidative retinal damage. EVALUATION OF HYPOTHESIS: Review of the literature related to ARMD and ApoE, using OVID as our main database, led to the development of several theories regarding ApoE epsilon4's behavior compared to epsilon3 and potential explanation of its protective characteristics. CONSEQUENCES OF HYPOTHESIS: We relate these theories to the potential behavior of ApoE epsilon4 in other situations including choroidal neovascularization, Alzheimer's Disease (AD), cardiovascular disease, herpes simplex virus infection, and smoking. DISCUSSION: The potential implications of this theory could be used as a branching point for further studies that examine the role of the different apoE isoforms, in relation to the other risk factors for ARMD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17141963      PMCID: PMC1857420          DOI: 10.1016/j.mehy.2006.09.049

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  28 in total

1.  Apolipoprotein localization in isolated drusen and retinal apolipoprotein gene expression.

Authors:  Chuan-Ming Li; Mark E Clark; Melissa F Chimento; Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

Review 2.  The genetics of age-related macular degeneration: a review of progress to date.

Authors:  Stephen Haddad; Clara A Chen; Susan L Santangelo; Johanna M Seddon
Journal:  Surv Ophthalmol       Date:  2006 Jul-Aug       Impact factor: 6.048

3.  Correlation of vasa vasorum neovascularization and plaque progression in aortas of apolipoprotein E(-/-)/low-density lipoprotein(-/-) double knockout mice.

Authors:  Alexander C Langheinrich; Agata Michniewicz; Daniel G Sedding; Gerhard Walker; Patricia E Beighley; Wigbert S Rau; Rainer M Bohle; Erik L Ritman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-11-17       Impact factor: 8.311

Review 4.  Cholesterol and 24S-hydroxycholesterol trafficking in Alzheimer's disease.

Authors:  Walter J Lukiw
Journal:  Expert Rev Neurother       Date:  2006-05       Impact factor: 4.618

5.  APOE genotype in cerebrovascular disease and vascular dementia.

Authors:  A Frank; E Díez-Tejedor; M J Bullido; F Valdivieso; P Barreiro
Journal:  J Neurol Sci       Date:  2002-11-15       Impact factor: 3.181

Review 6.  Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease.

Authors:  Robert W Mahley; Karl H Weisgraber; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-27       Impact factor: 11.205

7.  Association of the apolipoprotein E gene with age-related macular degeneration: possible effect modification by family history, age, and gender.

Authors:  S Schmidt; A M Saunders; E A Postel; R M Heinis; A Agarwal; W K Scott; J R Gilbert; J G McDowell; A Bazyk; J D Gass; J L Haines; M A Pericak-Vance
Journal:  Mol Vis       Date:  2000-12-31       Impact factor: 2.367

8.  Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study.

Authors:  Tien Yin Wong; Anoop Shankar; Ronald Klein; Molly S Bray; David J Couper; Barbara E K Klein; A Richey Sharrett; Aaron R Folsom
Journal:  Ophthalmology       Date:  2006-01-10       Impact factor: 12.079

9.  Lack of an association of apolipoprotein E gene polymorphisms with familial age-related macular degeneration.

Authors:  Dennis W Schultz; Michael L Klein; Andrea Humpert; Jacek Majewski; Mitchell Schain; Richard G Weleber; Jurg Ott; Ted S Acott
Journal:  Arch Ophthalmol       Date:  2003-05

10.  The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration.

Authors:  Lincoln V Johnson; William P Leitner; Alexander J Rivest; Michelle K Staples; Monte J Radeke; Don H Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-20       Impact factor: 11.205

View more
  3 in total

Review 1.  LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis.

Authors:  Yu Tong; Jing Liao; Yuan Zhang; Jing Zhou; Hengyu Zhang; Meng Mao
Journal:  Mol Vis       Date:  2010-10-05       Impact factor: 2.367

2.  Retinal phenotyping of variants of Alzheimer's disease using ultra-widefield retinal images.

Authors:  Lajos Csincsik; Nicola Quinn; Keir X X Yong; Sebastian J Crutch; Tunde Peto; Imre Lengyel
Journal:  Alzheimers Dement (Amst)       Date:  2021-08-20

3.  Apolipoprotein E gene and age-related macular degeneration in a Chinese population.

Authors:  Erdan Sun; Apiradee Lim; Xipu Liu; Torkel Snellingen; Ningli Wang; Ningpu Liu
Journal:  Mol Vis       Date:  2011-04-20       Impact factor: 2.367

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.